300 mg powder for solution for infusion

for Price / Quote
for Documentation
for Questions

Now in Europe


Active Pharmaceutical Ingredient: 
landiolol hydrochloride


Pharmacotherapeutic group:
Beta-blocking agents, selective



  • Landiolol hydrochloride is indicated for supraventricular tachycardia and for rapid control of ventricular rate in patients with atrial fibrillation or atrial flutter in perioperative, postoperative, or other circumstances where short-term control of the ventricular rate with a short acting agent is desirable.
  • Landiolol hydrochloride is also indicated for non-compensatory sinus tachycardia where, in the physician’s judgment the rapid heart rate requires specific intervention.
  • Landiolol is not intended for use in chronic settings.


Package size:
One vial of 50 ml contains 300 mg powder for solution for infusion.


Additional dosage options:
Rapibloc® 20 mg/2 ml concentrate for solution for injection (5 ampules per pack)

Storchengasse, 1
+43 1 545 01 13 0

More products from this supplier